PetMed Express, Inc.
PetMed Express operates as a US-based pet pharmacy marketing prescription and non-prescription medications, health products, and supplies for dogs, cats, and horses. It offers non-prescription items like flea control and vitamins, as well as prescription medications for various conditions. The company also sells pet food, beds, crates, and other supplies through its website, app, support center, and direct mail/print marketing.
Overview
Sector
Pharmaceutical Retailers
Strengths
- No significant strengths identified based on the analyzed metrics.
Weaknesses
- With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
- Current Price to Earnings Ratio (100.00) is significantly higher than the sector mean (71.63).
- Analysts expect revenues to decline in the coming year.
- The company has high debt. Net Debt to EBITDA Ratio (100.00) is higher than the sector mean.
- EV/EBITDA (100.00) is significantly higher than the sector mean (51.44).
- EBITDA Margin (0.00%) appears relatively low.
Key Financial Data
| Indicator | Value |
|---|
| PER | 100.0 |
| EV/EBITDA | 100.0 |
| Price/Free Cash Flow' | 100.0 |
| ROIC | 1.8% |
| Net Debt/EBITDA | 100.0 |